No products in the cart.
Remdesivir does not reduce mortality in ventilated patients with COVID-19
1. No significant decrease in mortality risk was seen in ventilated patients with COVID-19 on remdesivir compared to control. 2. ...
Tag: hydroxychloroquine
Hydroxychloroquine and lopinavir-ritonavir not effective against SARS-CoV-2
1. Hydroxychloroquine and lopinavir-ritonavir did not significantly decrease COVID-19–associated hospitalization or improve other secondary clinical outcomes. Evidence Rating Level: 1 ...
#VisualAbstract: Hydroxychloroquine not effective for preventing COVID-19 after contact exposure
1. Postexposure hydroxychloroquine therapy did not prevent coronavirus disease 2019 (Covid-19) infection in exposed healthy individuals. 2. Hydroxychloroquine treatment after ...
Hydroxychloroquine may not prevent Covid-19 after contact exposure
1. Postexposure hydroxychloroquine therapy did not prevent coronavirus disease 2019 (Covid-19) infection in exposed healthy individuals. 2. Hydroxychloroquine treatment after ...
Adding azithromycin to hydroxychloroquine does not improve clinical outcomes in COVID-19 patients
1. The addition of azithromycin to standard of care, which included hydroxychloroquine, did not improve clinical outcomes compared to standard ...
#VisualAbstract: No mortality benefit found for hydroxychloroquine or tocilizumab for the treatment of COVID-19
1. Hydroxychloroquine use in hospitalized and tocilizumab use in ICU lab-positive COVID-19 patients were not been associated with decreased death. ...
No mortality benefit found for hydroxychloroquine or tocilizumab for the treatment of COVID-19
1. Hydroxychloroquine use in hospitalized and tocilizumab use in ICU lab-positive COVID-19 patients were not been associated with decreased death. ...
#VisualAbstract: Prophylactic use of hydroxychloroquine did not decrease cumulative incidence of COVID-19
1. Prophylactic use of hydroxychloroquine within four days after exposure did not decrease cumulative incidence of coronavirus disease 2019 (Covid-19). ...
#VisualAbstract: Hydroxychloroquine with/without azithromycin for mild to moderate SARS-CoV-2
1. Metformin was found to be safe and tolerable in survivors of pediatric brain tumors. 2. Metformin was associated with ...
Postexposure prophylactic use of hydroxychloroquine not effective for Covid-19 prevention
1. Prophylactic use of hydroxychloroquine within four days after exposure did not decrease cumulative incidence of coronavirus disease 2019 (Covid-19). ...
License Our Award-Winning Physician-Written Medical News and Visual Abstracts
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.